{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:39:08Z","timestamp":1781005148702,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The impact of underlying immune-mediated inflammatory diseases (IMID) in patients undergoing hematopoietic stem cell transplant (HSCT) is unclear. Hematopoietic cell transplantation co-morbidity index (HCT-CI) is gaining acceptance as a reliable clinical method to score pre-transplant co-morbidities. Higher HCT-CI from a co-morbid IMID implies higher NRM. However, HCT-CI integrates many IMIDs with different pathogenesis and treatment together which may lead to spurious results. We performed a cross-sectional study using Nationwide Inpatient Sample dataset from 1998 to 2011 to compare the outcomes of HSCT in patients with different co-morbid IMIDs with patients without any co-morbid IMIDs. In both our multivariate and stringent matched-pair analysis, ulcerative colitis (UC) was associated with increased mortality while rheumatoid arthritis and psoriasis were associated with lower mortality as compared to no IMID group. Furthermore, in allogeneic HSCT subgroup, UC was associated with higher mortality and psoriasis was associated with lower mortality. In conclusion, we found that depending on the type of HSCT, each IMID has a different impact on outcomes of HSCT. Furthermore, UC patients had increased mortality if they had primary sclerosing cholangitis and had a higher risk of opportunistic infections like tuberculosis and cytomegalovirus suggesting the need for increased vigilance in this cohort.<\/jats:p>","DOI":"10.1038\/s41598-018-24060-4","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T11:54:57Z","timestamp":1524657297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study"],"prefix":"10.1038","volume":"8","author":[{"given":"Kathan","family":"Mehta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palashkumar","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farren","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Faubion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Tabibian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Cominelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"24060_CR1","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMra052638","volume":"354","author":"EA Copelan","year":"2006","unstructured":"Copelan, E. A. Hematopoietic stem-cell transplantation. N Engl J Med 354, 1813\u20131826, https:\/\/doi.org\/10.1056\/NEJMra052638 (2006).","journal-title":"N Engl J Med"},{"key":"24060_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1086\/339202","volume":"34","author":"KA Marr","year":"2002","unstructured":"Marr, K. A., Carter, R. A., Crippa, F., Wald, A. & Corey, L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34, 909\u2013917, https:\/\/doi.org\/10.1086\/339202 (2002).","journal-title":"Clin Infect Dis"},{"key":"24060_CR3","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood-2003-10-3616","volume":"103","author":"M Boeckh","year":"2004","unstructured":"Boeckh, M. & Nichols, W. G. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 103, 2003\u20132008, https:\/\/doi.org\/10.1182\/blood-2003-10-3616 (2004).","journal-title":"Blood"},{"key":"24060_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","volume":"36","author":"A Gratwohl","year":"2005","unstructured":"Gratwohl, A. et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 36, 757\u2013769, https:\/\/doi.org\/10.1038\/sj.bmt.1705140 (2005).","journal-title":"Bone Marrow Transplant"},{"key":"24060_CR5","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley, T. A. et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363, 2091\u20132101, https:\/\/doi.org\/10.1056\/NEJMoa1004383 (2010).","journal-title":"N Engl J Med"},{"key":"24060_CR6","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","volume":"31","author":"T Hahn","year":"2013","unstructured":"Hahn, T. et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. J Clin Oncol 31, 2437\u20132449, https:\/\/doi.org\/10.1200\/JCO.2012.46.6193 (2013).","journal-title":"J Clin Oncol"},{"key":"24060_CR7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.bbmt.2013.04.027","volume":"19","author":"PL McCarthy Jr.","year":"2013","unstructured":"McCarthy, P. L. Jr. et al. Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995\u20132005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age. Biol Blood Marrow Transplant 19, 1116\u20131123, https:\/\/doi.org\/10.1016\/j.bbmt.2013.04.027 (2013).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR8","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror, M. L. et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 106, 2912\u20132919, https:\/\/doi.org\/10.1182\/blood-2005-05-2004 (2005).","journal-title":"Blood"},{"key":"24060_CR9","unstructured":"National Institutes of Health Autoimmune Disease Coordinating Committee Report. In. Bethesda (MD), (https:\/\/www.niaid.nih.gov\/topics\/autoimmune\/Pages\/coordComm.aspx) (2002)."},{"key":"24060_CR10","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2105\/AJPH.90.9.1463","volume":"90","author":"SJ Walsh","year":"2000","unstructured":"Walsh, S. J. & Rau, L. M. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health 90, 1463\u20131466 (2000).","journal-title":"Am J Public Health"},{"key":"24060_CR11","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1002\/ibd.21497","volume":"17","author":"S Cucchiara","year":"2011","unstructured":"Cucchiara, S. & Stronati, L. Incidence in pediatric IBD is rising: help from health administrative data. Inflamm Bowel Dis 17, 1048\u20131049, https:\/\/doi.org\/10.1002\/ibd.21497 (2011).","journal-title":"Inflamm Bowel Dis"},{"key":"24060_CR12","doi-asserted-by":"publisher","unstructured":"Molodecky, N. A. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46\u201354 e42, quize30, https:\/\/doi.org\/10.1053\/j.gastro.2011.10.001 (2012).","DOI":"10.1053\/j.gastro.2011.10.001"},{"key":"24060_CR13","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.27425","volume":"62","author":"E Myasoedova","year":"2010","unstructured":"Myasoedova, E., Crowson, C. S., Kremers, H. M., Therneau, T. M. & Gabriel, S. E. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955\u20132007. Arthritis Rheum 62, 1576\u20131582, https:\/\/doi.org\/10.1002\/art.27425 (2010).","journal-title":"Arthritis Rheum"},{"key":"24060_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.38238","volume":"66","author":"EC Somers","year":"2014","unstructured":"Somers, E. C. et al. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program. Arthritis Rheumatol 66, 369\u2013378, https:\/\/doi.org\/10.1002\/art.38238 (2014).","journal-title":"Arthritis Rheumatol"},{"key":"24060_CR15","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","volume":"16","author":"NS Majhail","year":"2010","unstructured":"Majhail, N. S., Omondi, N. A., Denzen, E., Murphy, E. A. & Rizzo, J. D. Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 16, 1070\u20131075, https:\/\/doi.org\/10.1016\/j.bbmt.2009.12.529 (2010).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMra020100","volume":"347","author":"JF Bach","year":"2002","unstructured":"Bach, J. F. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347, 911\u2013920, https:\/\/doi.org\/10.1056\/NEJMra020100 (2002).","journal-title":"N Engl J Med"},{"key":"24060_CR17","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1056\/NEJMra1100030","volume":"365","author":"JH Cho","year":"2011","unstructured":"Cho, J. H. & Gregersen, P. K. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365, 1612\u20131623, https:\/\/doi.org\/10.1056\/NEJMra1100030 (2011).","journal-title":"N Engl J Med"},{"key":"24060_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.gtc.2014.05.003","volume":"43","author":"M Dave","year":"2014","unstructured":"Dave, M., Papadakis, K. A. & Faubion, W. A. Jr. Immunology of inflammatory bowel disease and molecular targets for biologics. Gastroenterol Clin North Am 43, 405\u2013424, https:\/\/doi.org\/10.1016\/j.gtc.2014.05.003 (2014).","journal-title":"Gastroenterol Clin North Am"},{"key":"24060_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson, A. & Diamond, B. Autoimmune diseases. N Engl J Med 345, 340\u2013350, https:\/\/doi.org\/10.1056\/NEJM200108023450506 (2001).","journal-title":"N Engl J Med"},{"key":"24060_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2014-01-550566","volume":"124","author":"ML Sorror","year":"2014","unstructured":"Sorror, M. L. et al. Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood 124, 287\u2013295, https:\/\/doi.org\/10.1182\/blood-2014-01-550566 (2014).","journal-title":"Blood"},{"key":"24060_CR21","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.bbmt.2016.05.022","volume":"22","author":"F Rabian","year":"2016","unstructured":"Rabian, F. et al. Influence of Previous Inflammatory Bowel Disease on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Matched-Pair Analysis. Biol Blood Marrow Transplant 22, 1721\u20131724, https:\/\/doi.org\/10.1016\/j.bbmt.2016.05.022 (2016).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","volume":"358","author":"MA Atkinson","year":"2001","unstructured":"Atkinson, M. A. & Eisenbarth, G. S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358, 221\u2013229, https:\/\/doi.org\/10.1016\/S0140-6736(01)05415-0 (2001).","journal-title":"Lancet"},{"key":"24060_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/BOR.0b013e32834518a3","volume":"23","author":"FA Cooles","year":"2011","unstructured":"Cooles, F. A. & Isaacs, J. D. Pathophysiology of rheumatoid arthritis. Curr Opin Rheumatol 23, 233\u2013240, https:\/\/doi.org\/10.1097\/BOR.0b013e32834518a3 (2011).","journal-title":"Curr Opin Rheumatol"},{"key":"24060_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/bmj.332.7534.152","volume":"332","author":"P Emery","year":"2006","unstructured":"Emery, P. Treatment of rheumatoid arthritis. BMJ 332, 152\u2013155, https:\/\/doi.org\/10.1136\/bmj.332.7534.152 (2006).","journal-title":"BMJ"},{"key":"24060_CR25","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM200010193431610","volume":"343","author":"RJ Falk","year":"2000","unstructured":"Falk, R. J. Treatment of lupus nephritis\u2013a work in progress. N Engl J Med 343, 1182\u20131183, https:\/\/doi.org\/10.1056\/NEJM200010193431610 (2000).","journal-title":"N Engl J Med"},{"key":"24060_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.56.7.481","volume":"56","author":"CC Mok","year":"2003","unstructured":"Mok, C. C. & Lau, C. S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56, 481\u2013490 (2003).","journal-title":"J Clin Pathol"},{"key":"24060_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncpgasthep0528","volume":"3","author":"RB Sartor","year":"2006","unstructured":"Sartor, R. B. Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 3, 390\u2013407, https:\/\/doi.org\/10.1038\/ncpgasthep0528 (2006).","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"24060_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/SCCAA.S6815","volume":"3","author":"E Hatzimichael","year":"2010","unstructured":"Hatzimichael, E. & Tuthill, M. Hematopoietic stem cell transplantation. Stem Cells Cloning 3, 105\u2013117, https:\/\/doi.org\/10.2147\/SCCAA.S6815 (2010).","journal-title":"Stem Cells Cloning"},{"key":"24060_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1002\/cncr.23281","volume":"112","author":"JA Jones","year":"2008","unstructured":"Jones, J. A. et al. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 112, 1096\u20131105, https:\/\/doi.org\/10.1002\/cncr.23281 (2008).","journal-title":"Cancer"},{"key":"24060_CR30","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/0016-5085(91)90784-I","volume":"100","author":"R Olsson","year":"1991","unstructured":"Olsson, R. et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 100, 1319\u20131323 (1991).","journal-title":"Gastroenterology"},{"key":"24060_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/pr.2011.57","volume":"71","author":"T Daikeler","year":"2012","unstructured":"Daikeler, T., Tichelli, A. & Passweg, J. Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases. Pediatr Res 71, 439\u2013444, https:\/\/doi.org\/10.1038\/pr.2011.57 (2012).","journal-title":"Pediatr Res"},{"key":"24060_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbmt.2015.09.006","volume":"22","author":"J Inagaki","year":"2016","unstructured":"Inagaki, J. et al. Effect of Cytomegalovirus Reactivation on Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Leukemia. Biol Blood Marrow Transplant 22, 300\u2013306, https:\/\/doi.org\/10.1016\/j.bbmt.2015.09.006 (2016).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR33","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/tid.12115","volume":"15","author":"M Koldehoff","year":"2013","unstructured":"Koldehoff, M., Beelen, D. W. & Elmaagacli, A. H. Increased susceptibility for aspergillosis and post-transplant immune deficiency in patients with gene variants of TLR4 after stem cell transplantation. Transpl Infect Dis 15, 533\u2013539, https:\/\/doi.org\/10.1111\/tid.12115 (2013).","journal-title":"Transpl Infect Dis"},{"key":"24060_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbmt.2008.10.024","volume":"15","author":"M Mikulska","year":"2009","unstructured":"Mikulska, M. et al. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. Biol Blood Marrow Transplant 15, 47\u201353, https:\/\/doi.org\/10.1016\/j.bbmt.2008.10.024 (2009).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR35","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/bmt.2010.112","volume":"46","author":"DD Poutsiaka","year":"2011","unstructured":"Poutsiaka, D. D., Munson, D., Price, L. L., Chan, G. W. & Snydman, D. R. Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated. Bone Marrow Transplant 46, 300\u2013307, https:\/\/doi.org\/10.1038\/bmt.2010.112 (2011).","journal-title":"Bone Marrow Transplant"},{"key":"24060_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3324\/haematol.2013.087338","volume":"99","author":"M Uhlin","year":"2014","unstructured":"Uhlin, M. et al. Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation. Haematologica 99, 346\u2013352, https:\/\/doi.org\/10.3324\/haematol.2013.087338 (2014).","journal-title":"Haematologica"},{"key":"24060_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bbmt.2006.06.001","volume":"12","author":"LR Wang","year":"2006","unstructured":"Wang, L. R., Dong, L. J., Zhang, M. J. & Lu, D. P. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12, 1031\u20131037, https:\/\/doi.org\/10.1016\/j.bbmt.2006.06.001 (2006).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbmt.2016.10.017","volume":"23","author":"P Barba","year":"2017","unstructured":"Barba, P. et al. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 23, 67\u201374, https:\/\/doi.org\/10.1016\/j.bbmt.2016.10.017 (2017).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR39","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2007-06-096966","volume":"110","author":"ML Sorror","year":"2007","unstructured":"Sorror, M. L. et al. Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110, 4606\u20134613, https:\/\/doi.org\/10.1182\/blood-2007-06-096966 (2007).","journal-title":"Blood"},{"key":"24060_CR40","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes, J., Gower-Rousseau, C., Seksik, P. & Cortot, A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785\u20131794, https:\/\/doi.org\/10.1053\/j.gastro.2011.01.055 (2011).","journal-title":"Gastroenterology"},{"key":"24060_CR41","unstructured":"Center for International Blood and Marrow Transplant and Research (CIBMTR) home page. Available from: https:\/\/www.cibmtr.org\/Data\/Available\/Pages\/index.aspx."},{"key":"24060_CR42","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn, M. et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 15, 1143\u20131238, https:\/\/doi.org\/10.1016\/j.bbmt.2009.06.019 (2009).","journal-title":"Biol Blood Marrow Transplant"},{"key":"24060_CR43","unstructured":"HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Edited by: Agency for Healthcare Research and Quality, Rockville, MD; 2007\u20132009. (http:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp)."},{"key":"24060_CR44","doi-asserted-by":"publisher","unstructured":"Mehta, K., Im, A., Rahman, F., Wang, H. & Veldkamp, P. Epidemiology and Outcomes of Hematopoietic Stem Cell Transplant in HIV (+) Patients from 1998 to 2012: A Nationwide Analysis. Clin Infect Dis, https:\/\/doi.org\/10.1093\/cid\/ciy010 (2018).","DOI":"10.1093\/cid\/ciy010"},{"key":"24060_CR45","doi-asserted-by":"publisher","first-page":"c315","DOI":"10.1159\/000323136","volume":"118","author":"MA de Graaf","year":"2011","unstructured":"de Graaf, M. A., Jager, K. J., Zoccali, C. & Dekker, F. W. Matching, an appealing method to avoid confounding? Nephron Clin Pract 118, c315\u2013318, https:\/\/doi.org\/10.1159\/000323136 (2011).","journal-title":"Nephron Clin Pract"},{"key":"24060_CR46","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","volume":"12","author":"E von Elm","year":"2014","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 12, 1495\u20131499, https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.013 (2014).","journal-title":"Int J Surg"},{"key":"24060_CR47","unstructured":"Cormen TH CEL, a. R. L. R. Introduction To Algorithms: The MIT Press, (2011)."},{"key":"24060_CR48","unstructured":"CPI Inflation Calculator. Edited by: Bureau of Labor Statistics, (2015)."},{"key":"24060_CR49","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1161\/CIRCULATIONAHA.114.008201","volume":"129","author":"NJ Patel","year":"2014","unstructured":"Patel, N. J. et al. Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planning. Circulation 129, 2371\u20132379, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.008201 (2014).","journal-title":"Circulation"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24060-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24060-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24060-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:48:27Z","timestamp":1671598107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24060-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24060"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24060-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"18 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6825"}}